Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study-Reference-Cited by-同舟云学术

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

Published:2004-03 Issue:3 Volume:15 Page:511-516
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Jermann M.,Jost L.M.,Taverna Ch.,Jacky E.,Honegger H.P.,Betticher D.C.,Egli F.,Kroner Th.,Stahel R.A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/3/511/557947/mdh093.pdf

Reference23 articles.

1. Treatment of non-Hodgkin’s lymphoma;Armitage;N Engl J Med,1993

2. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma;Philip;N Engl J Med,1995

3. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin’s lymphoma: value of augmented preparative regimens—a Southwest Oncology Group trial;Stiff;J Clin Oncol,1998

4. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study;Coiffier;Blood,1998

5. Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH;Gutierrez;J Clin Oncol,2000

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Hodgkin lymphoma treated with anti-CD20 antibody-based immunochemotherapy;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

2. Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma;Pediatric Health, Medicine and Therapeutics;2023-10

3. Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study;Cancer Medicine;2023-08-28

4. DA-EPOCH-R improves the prognosis of patients with double-expressor lymphoma: A single-center retrospective study and meta-analysis;Medicine;2022-09-23

5. Cancers of the Blood;Fundamentals of Cancer Detection, Treatment, and Prevention;2022-05-13